Literature DB >> 7795884

Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells.

G Klein1, S Conzelmann, S Beck, R Timpl, C A Müller.   

Abstract

Human perlecan is a heparan sulfate proteoglycan with a large core protein of 467 kDa to which three glycosaminoglycan side chains are attached. It belongs to the heparan sulfate proteoglycan family which has been implicated in strong interactions between developing hematopoietic cells and their microenvironment in the bone marrow. Here we report that perlecan is highly expressed in the human bone marrow, as well as in long-term bone marrow cultures which are thought to mimic hematopoiesis in vitro. Expression of perlecan in this tissue was shown by Northern blotting of the 14-kb mRNA of the core protein and by immunofluorescence stainings. Functionally, perlecan shows a strong anti-adhesive effect on unfractionated bone marrow cells and on various hematopoietic cell lines, repelling the cells from the perlecan-coated area. In contrast, perlecan is adhesive for fibroblasts and endothelial cells. It is suggested that the anti-adhesive site is located within the core protein of perlecan since heparitinase-treated perlecan still shows the repellent effect. Although anti-adhesive for hematopoietic cells, perlecan is able to bind growth factors like granulocyte/macrophage-colony stimulating factor and present them to hematopoietic progenitor cells in a semi-solid colony assay. The functional role of a growth-factor-binding extracellular matrix component in the bone marrow microenvironment with anti-adhesive properties is uncertain but may be related to compartmentalization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795884     DOI: 10.1016/0945-053x(95)90003-9

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  19 in total

1.  Clinicopathological significance of heparanase and basic fibroblast growth factor expression in human esophageal cancer.

Authors:  Biao Han; Jian Liu; Min-Jie Ma; Lin Zhao
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 2.  Death and inflammation following somatic cell transplantation.

Authors:  Ian B Copland; Jacques Galipeau
Journal:  Semin Immunopathol       Date:  2011-05-01       Impact factor: 9.623

3.  Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Authors:  Muneaki Ishijima; Nobuharu Suzuki; Kentaro Hozumi; Tomoya Matsunobu; Keisuke Kosaki; Haruka Kaneko; John R Hassell; Eri Arikawa-Hirasawa; Yoshihiko Yamada
Journal:  Matrix Biol       Date:  2012-03-07       Impact factor: 11.583

Review 4.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

Review 5.  The extracellular matrix of the hematopoietic microenvironment.

Authors:  G Klein
Journal:  Experientia       Date:  1995-09-29

Review 6.  Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells.

Authors:  Dulce Papy-Garcia; Patricia Albanese
Journal:  Glycoconj J       Date:  2017-06-02       Impact factor: 2.916

7.  Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.

Authors:  Timo Vögtle; Sumana Sharma; Jun Mori; Zoltan Nagy; Daniela Semeniak; Cyril Scandola; Mitchell J Geer; Christopher W Smith; Jordan Lane; Scott Pollack; Riitta Lassila; Annukka Jouppila; Alastair J Barr; Derek J Ogg; Tina D Howard; Helen J McMiken; Juli Warwicker; Catherine Geh; Rachel Rowlinson; W Mark Abbott; Anita Eckly; Harald Schulze; Gavin J Wright; Alexandra Mazharian; Klaus Fütterer; Sundaresan Rajesh; Michael R Douglas; Yotis A Senis
Journal:  Elife       Date:  2019-08-22       Impact factor: 8.140

8.  Perlecan: an important component of the cartilage pericellular matrix.

Authors:  R Gomes; C Kirn-Safran; M C Farach-Carson; D D Carson
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-12       Impact factor: 2.041

Review 9.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

10.  The proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph gland.

Authors:  Melina Grigorian; Ting Liu; Utpal Banerjee; Volker Hartenstein
Journal:  Dev Biol       Date:  2013-03-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.